CLINICAL TRIALS AT
SCCA has over 200 clinical trials open for patients and intends to lead the world in translating scientific discovery into the prevention, diagnosis, treatment and cure of cancer.
Recently Opened Trials
Cellular Adoptive Immunotherapy Using Autologous Tumor-Infiltrating Lymphocytes Following Lymphodepletion With Cyclophosphamide and Fludarabine For Patients With Metastatic Melanoma
A phase 1b dose-escalation study of SGN-CD33A in combination with standard-of-care for patients with newly diagnosed acute myeloid leukemia (AML)
A pilot trial of NY-ESO-1-specific T cells in patients with metastatic NY-ESO-1-expressing sarcomas receiving palliative radiation
A Phase II Study of MK-3475 in Patients with Advanced Merkel Cell Carcinoma (MCC)
A Phase I Trial of the Safety and Immunogenicity of a Multiple Antigen Vaccine (STEMVAC) in HER2 Negative Advanced Stage Breast Cancer Patients